DXCM
NasdaqDEXCOM, INC.
Technology · Surgical & Medical Instruments & Apparatus
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$2.4B
2021
$2.9B
2022
$3.6B
2023
$4.0B
2024
$4.7B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$4.7B
Net Income$836.3M
Gross Profit$2.8B
Oper Income$911.8M
EPS (dil)$2.09
Rev/sh$12.08
FCF/sh$2.79
Book/sh$7.12
Gross M60.1%
Oper M19.6%
Profit M17.9%
FCF M23.1%
ROE30.5%
ROA13.2%
ROIC38.3%
R&D/Rev12.9%
Rev Y/Y15.6%
Rev 3Y CAGR17.0%
EPS Y/Y47.2%
EPS 3Y CAGR36.6%
FCF 3Y CAGR52.3%
Payout—
Div/sh—
Shs Chg Y/Y-1.7%
Current Ratio1.88
Quick Ratio1.59
Debt/Eq0.00
Int Coverage49.8×
Net Debt$916.2M cash
Total Debt$2.9M
Cash & Eq$919.1M
Total Assets$6.3B
Oper CF$1.4B
Capex$363.5M
Free CF$1.1B
Buybacks$500.0M
Equity$2.7B
Liabilities$3.6B
Shs Outstand0.39B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.9B | $3.6B | $4.0B | $4.7B |
| Gross Profit | $1.7B | $1.9B | $2.3B | $2.4B | $2.8B |
| Operating Income | $265.8M | $391.2M | $597.7M | $600.0M | $911.8M |
| Net Income | $216.9M | $341.2M | $541.5M | $576.2M | $836.3M |
| Diluted EPS | $0.53 | $0.82 | $1.30 | $1.42 | $2.09 |
| Operating Cash Flow | $442.5M | $669.5M | $748.5M | $989.5M | $1.4B |
| Free Cash Flow | $53.3M | $304.7M | $511.9M | $630.7M | $1.1B |
COMMUNITY · $DXCM0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.